Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Amedeo Capetti"'
Autor:
Massimiliano Fabbiani, Melissa Masini, Barbara Rossetti, Arturo Ciccullo, Vanni Borghi, Filippo Lagi, Amedeo Capetti, Manuela Colafigli, Francesca Panza, Gianmaria Baldin, Cristina Mussini, Gaetana Sterrantino, Damiano Farinacci, Francesca Montagnani, Mario Tumbarello, Simona Di Giambenedetto
Publikováno v:
Viruses, Vol 15, Iss 5, p 1123 (2023)
Background: Since limited data are available, we aimed to compare the efficacy and durability of dolutegravir and darunavir in advanced naïve patients. Methods: Retrospective multicenter study including AIDS- or late-presenting (def. CD4 ≤ 200/µL
Externí odkaz:
https://doaj.org/article/c454bec1cda24135adfdd8fe2956e78a
Autor:
Arturo Ciccullo, Gianmaria Baldin, Vanni Borghi, Filippo Lagi, Alessandra Latini, Gabriella d’Ettorre, Letizia Oreni, Paolo Fusco, Amedeo Capetti, Massimiliano Fabbiani, Andrea Giacomelli, Alessandro Grimaldi, Giordano Madeddu, Gaetana Sterrantino, Cristina Mussini, Simona Di Giambenedetto
Publikováno v:
Viruses, Vol 14, Iss 1, p 163 (2022)
Dolutegravir (DTG) is currently one of the most used Integrase inhibitors (INI) in antiretroviral therapies (ARV) in both naïve and experienced people living with HIV (PLWHIV). We analyzed a multicenter cohort of PLWHIV, both naïve and experienced,
Externí odkaz:
https://doaj.org/article/df7280bebe6849ceb48d8ea89dfc8feb
Autor:
Stefano Rusconi, Paola Vitiello, Fulvio Adorni, Elisa Colella, Emanuele Focà, Amedeo Capetti, Paola Meraviglia, Clara Abeli, Stefano Bonora, Marco D'Annunzio, Antonio Di Biagio, Massimo Di Pietro, Luca Butini, Giancarlo Orofino, Manuela Colafigli, Gabriella d'Ettorre, Daniela Francisci, Giustino Parruti, Alessandro Soria, Anna Rita Buonomini, Chiara Tommasi, Silvia Mosti, Francesca Bai, Silvia Di Nardo Stuppino, Manuela Morosi, Marco Montano, Pamela Tau, Esther Merlini, Giulia Marchetti
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80157 (2013)
BackgroundImmunological non-responders (INRs) lacked CD4 increase despite HIV-viremia suppression on HAART and had an increased risk of disease progression. We assessed immune reconstitution profile upon intensification with maraviroc in INRs.Methods
Externí odkaz:
https://doaj.org/article/fde61c47e2224ac98aa3fcc74da66426
Autor:
Amedeo Capetti, Simona Landonio, Paola Meraviglia, Antonio Di Biagio, Sergio Lo Caputo, Gaetana Sterrantino, Adriana Ammassari, Barbara Menzaghi, Marco Franzetti, Giuseppe Vittorio De Socio, Giovanni Pellicanò, Elena Mazzotta, Alessandro Soria, Marianna Meschiari, Michele Trezzi, Lolita Sasset, Benedetto Maurizio Celesia, Patrizia Zucchi, Sara Melzi, Elena Ricci, Giuliano Rizzardini
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e39222 (2012)
BackgroundLong term efficacy of raltegravir (RAL)-including regimens in highly pre-treated HIV-1-infected patients has been demonstrated in registration trials. However, few studies have assessed durability in routine clinical settings.MethodsAntiret
Externí odkaz:
https://doaj.org/article/fcec1bdc8aa6404abf2b96fb1dc669cc
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding
Autor:
Andrea Giacometti, Gabriella d'Ettorre, Amedeo Capetti, William Gennari, Stefano Rusconi, Gaetana Sterrantino, Andrea Giacomelli, Vanni Borghi, Gianmaria Baldin, Alessandra Latini, Andrea De Vito, Cristina Mussini, Arturo Ciccullo, Simona Di Giambenedetto, Giordano Madeddu, Maria Vittoria Cossu
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 88:234-237
BACKGROUND Results from clinical trials and observational studies suggest that dolutegravir plus lamivudine could be an effective and well-tolerated option for simplification in HIV-1-positive patients. We aimed to assess long-time efficacy and safet
Autor:
Alberto Rizzo, Giacomo Pozza, Federica Salari, Andrea Giacomelli, Davide Mileto, Maria Vittoria Cossu, Alessandro Mancon, Gloria Gagliardi, Bianchi Micol, Valeria Micheli, Amedeo Capetti, Spinello Antinori, Maria Rita Gismondo, Pietro Olivieri, Alessandra Lombardi
Publikováno v:
Journal of Medical Virology. 95
In 2022, many monkeypox (MPX) outbreaks have been documented in countries where MPX was not endemic. It spread all around the world, especially in European Union and United States. While MPX is classically considered to be transmitted through close c
Autor:
Paola Meraviglia, Amedeo Capetti, Valeria Micheli, Cecilia Bonazzetti, Maria Albrecht, Letizia Oreni, Alessandro Mancon, Giuliano Rizzardini, Andrea Giacomelli, Matteo Passerini, Maria Vittoria Cossu, Stefania Vimercati, Federico Conti, Anna Lisa Ridolfo, Laura Pezzati, Massimo Galli, Spinello Antinori
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Background: We assessed the impact of the coronavirus disease 2019 (COVID-19) pandemic on HIV suppression rates in people living with HIV (PLWH) attending a large Italian HIV clinic. Setting: The HIV outpatient clinic of the Infectious Diseases Depar
Autor:
Matteo Passerini, Martina Gerbi, Marco Piscaglia, Giuliano Rizzardini, Amedeo Capetti, Chiara Fusetti, Maria Vittoria Cossu, Francesco Petri
Publikováno v:
Expert Opinion on Emerging Drugs. 26:219-230
Introduction: The study of emerging drug trials to treat people living with HIV (PLWH) helps to understand any advantages and disadvantages of therapies that will be available on the market in the short-term future as well as the mechanisms underlyin
Autor:
Andrea Giacomelli, Fabio Borgonovo, Angelica Lupo, Valentina Morena, Gianfranco Dedivitiis, Stefania Falvella, Letizia Oreni, Amedeo Capetti, Maria Vittoria Cossu, Matteo Passerini, Marco Piscaglia
Publikováno v:
The Journal of Infection
Journal of Infection
Journal of Infection
Autor:
Gianfranco Dedivitiis, Chiara Mariani, Paola Meraviglia, Fabio Borgonovo, Gloria Gagliardi, Maria Vittoria Cossu, Giuliano Rizzardini, Martina Pellicciotta, Davide Mileto, Angelica Lupo, Luciana Armiento, Amedeo Capetti
Publikováno v:
The Journal of Infection
Data are presented of 368/503 post-COVID-19 outpatients followed within the AntiCROWN Cohort who have a one-year control and a baseline assessment of anti-S1/S2 antibodies, detected with the The LIAISON® SARS-CoV-2 S1/S2 IgG solution by DiaSorin. Lo